Suppr超能文献

重度慢性阻塞性肺疾病(COPD)患者的急性加重期。采用鼻罩正压通气治疗。

Acute exacerbations in severe COLD patients. Treatment using positive pressure ventilation by nasal mask.

作者信息

Foglio C, Vitacca M, Quadri A, Scalvini S, Marangoni S, Ambrosino N

机构信息

Fondazione Clinica del Lavoro, Department of Medical Rehabilitation, Gussago, Italy.

出版信息

Chest. 1992 Jun;101(6):1533-8. doi: 10.1378/chest.101.6.1533.

Abstract

We retrospectively evaluated the clinical effectiveness of a treatment schedule with intermittent positive pressure ventilation via nasal mask in 49 patients with acute exacerbations of COLD. According to the ability to successfully tolerate a preliminary trial with NIPPV, patients were submitted either to standard treatment plus NIPPV (25 patients) or to ST alone (24 patients). The ST consisted of medical, oxygen and physical therapy. The NIPPV was delivered by a volume cycled ventilator in control mode at least 4 h a day for five consecutive days a week, for three weeks. Comparison of baseline with measurements performed after 10 and 21 days of treatment respectively showed a significant improvement in PaO2 and in PaCO2 in both groups. After 21 days of treatment, VC, FEV1, inspiratory muscle strength, and dyspnea significantly improved in both groups. No significant difference was found between groups at any time of treatment. We conclude that the treatment schedule of NIPPV used is not more effective than ST alone in acute exacerbations of COLD.

摘要

我们回顾性评估了49例慢性阻塞性肺疾病(COLD)急性加重期患者采用经鼻面罩间歇正压通气治疗方案的临床疗效。根据能否成功耐受无创正压通气(NIPPV)的初步试验,患者被分为两组,一组接受标准治疗加NIPPV(25例患者),另一组仅接受标准治疗(ST,24例患者)。标准治疗包括药物治疗、吸氧和物理治疗。NIPPV由容量控制型呼吸机以控制模式每天至少使用4小时,每周连续使用5天,共持续3周。分别比较治疗10天和21天后的测量值与基线值,结果显示两组患者的动脉血氧分压(PaO2)和动脉血二氧化碳分压(PaCO2)均有显著改善。治疗21天后,两组患者的肺活量(VC)、第一秒用力呼气容积(FEV1)、吸气肌力量和呼吸困难症状均有显著改善。在治疗的任何时间点,两组之间均未发现显著差异。我们得出结论,在COLD急性加重期,所采用的NIPPV治疗方案并不比单纯标准治疗更有效。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验